The FDA intends to exercise enforcement discretion with respect to certain products labeled as dietary supplements that contain N-acetyl-L-cysteine (NAC). A final guidance document, “Policy Regarding N-acetyl-L-cysteine: Guidance for Industry,” outlines the agency’s position with respect to the sale and distribution of products that are labeled as dietary supplements and conta... Read More